Professionals 155 results
Capabilities 29 results
Industry
Practice Area
Industry
Experience 10 results
Experience
|February 12, 2024
Experience
|December 20, 2021
ACON Investments' Acquisition of Vitalis Group
Experience
|December 15, 2021
Arbor Investments' Acquisition of Oregon Freeze Dry
Insights & News 275 results
Product Liability & Mass Torts Digest
|July 2, 2024
|6 Min Read
The California Supreme Court has recognized a new path for plaintiffs to prove causation in failure-to-warn cases against manufacturers of prescription drugs and medical devices. Under the learned intermediary doctrine, such manufacturers have a duty to warn physicians of the risks associated with their products but do not have a duty to warn patients.
Product Liability & Mass Torts Digest
|June 27, 2024
|4 Min Read
As part of the wider multidistrict litigation over the breast cancer drug docetaxel (branded Taxotere), on May 24, 2024, the Fifth Circuit ruled that Food and Drug Administration (FDA) labeling requirements preempt certain state law failure-to-warn theories. Hickey v. Hospira, 102 F.4th 748 (5th Cir. 2024).
Recognitions
|June 12, 2024
|2 Min Read
Winston & Strawn Recognized in The Legal 500 U.S. 2024
Other Results 27 results
Law Glossary
Law Glossary
Law Glossary
How Does an Applicant Establish Biosimilarity?